To uncover the mechanism of the EphA2‐S897 phosphorylation, we used inhibitors against the kinases reported to phosphorylate the receptor in other cancers (Miao et al, 2009; Zhou et al, 2015; Barquilla et al, 2016). The gene discussed is EPHA2; the disease is cancer.